Lack of defect in insulin action on hepatic glycogen synthase and phosphorylase in insulin-resistant monkeys

被引:11
|
作者
Ortmeyer, HK [1 ]
Bodkin, NL [1 ]
机构
[1] Univ Maryland, Sch Med, Dept Physiol, Obes & Diabet Res Ctr, Baltimore, MD 21201 USA
关键词
glucose; 6-phosphate; whole body insulin-mediated glucose disposal rate; skeletal muscle; adipose tissue;
D O I
10.1152/ajpgi.1998.274.6.G1005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
It is well known that an alteration in insulin activation of skeletal muscle glycogen synthase is associated with insulin resistance. To determine whether this defect in insulin action is specific to skeletal muscle, or also present in liver, simultaneous biopsies of these tissues were obtained before and during a euglycemic hyperinsulinemic clamp in spontaneously obese insulin-resistant male rhesus monkeys. The activities of glycogen synthase and glycogen phosphorylase and the concentrations of glucose 6-phosphate and glycogen were measured. There were no differences between basal and insulin-stimulated glycogen synthase and glycogen phosphorylase activities or in glucose 6-phosphate and glycogen contents in muscle. Insulin increased the activities of Liver glycogen synthase (P < 0.05) and decreased the activities of liver glycogen phosphorylase (P less than or equal to 0.001). Insulin also caused a reduction in liver glucose 6-phosphate (P = 0.05). We conclude that insulin-resistant monkeys do not have a defect in insulin action on liver glycogen synthase, although a defect in insulin action on muscle glycogen synthase is present. Therefore, tissue-specific alterations in insulin action on glycogen synthase are present in the development of insulin resistance in rhesus monkeys.
引用
收藏
页码:G1005 / G1010
页数:6
相关论文
共 50 条
  • [11] Regulation of glycogen concentration and glycogen synthase activity in skeletal muscle of insulin-resistant rats
    Coderre, Lise
    Vallega, Gino A.
    Pilch, Paul F.
    Chipkin, Stuart R.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2007, 464 (01) : 144 - 150
  • [12] Effects of rosiglitazone on skeletal muscle metabolism and insulin action in insulin-resistant monkeys.
    Ortmeyer, HK
    Bodkin, NL
    Smith, SA
    Hansen, BC
    DIABETOLOGIA, 2000, 43 : A68 - A68
  • [13] Progressive defect of insulin action on glycogen synthase in obesity and diabetes
    Golay, A
    Munger, R
    Assimacopoulos-Jeannet, F
    Bobbioni-Harsch, E
    Habicht, F
    Felber, JP
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (05): : 549 - 553
  • [14] ACTION OF PREDNISONE IN INSULIN-RESISTANT DIABETES
    OAKLEY, W
    FIELD, JB
    SOWTON, GE
    RIGBY, B
    CUNLIFFE, AC
    BRITISH MEDICAL JOURNAL, 1959, 1 (JUN27): : 1601 - 1606
  • [15] DEFECTIVE INSULIN-RESPONSE OF PHOSPHORYLASE-PHOSPHATASE IN INSULIN-RESISTANT HUMANS
    KIDA, Y
    RAZ, I
    MAEDA, R
    NYOMBA, BL
    STONE, K
    BOGARDUS, C
    SOMMERCORN, J
    MOTT, DM
    JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02): : 610 - 617
  • [16] ADIPOSE-TISSUE GLYCOGEN-SYNTHASE ACTIVATION BY INVIVO INSULIN IN SPONTANEOUSLY INSULIN-RESISTANT AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC RHESUS-MONKEYS
    ORTMEYER, HK
    BODKIN, NL
    HANSEN, BC
    DIABETOLOGIA, 1993, 36 (03) : 200 - 206
  • [17] Inhibition of glycogen phosphorylase attenuates hepatic glucose disposal in normal and insulin resistant rats
    Rakipovski, G.
    Jensen, M. W.
    Pedersen, K. E.
    Andersen, H.
    Breinholt, I.
    Fosgerau, K.
    DIABETOLOGIA, 2007, 50 : S256 - S256
  • [18] Molecular mechanisms of insulin action in normal and insulin-resistant states
    Le Marchand-Brustel, Y
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 (02) : 126 - 132
  • [19] Dual action of adiponectin on insulin secretion in insulin-resistant mice
    Winzell, MS
    Nogueiras, R
    Dieguez, C
    Ahrén, B
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (01) : 154 - 160
  • [20] Inhibition of glycogen synthase kinase-3 in vitro enhances distal insulin signaling in insulin-resistant skeletal muscle
    Dokken, BB
    Henriksen, EJ
    DIABETES, 2004, 53 : A325 - A325